Journal profile
ImmunoMedicine
ISSN 2510-5345 · Wiley · United States
ImmunoMedicine: fully open access; APC about USD 2,870; review about 30 weeks (community reports); 0 articles in 2025.
Scope
Aims, scope and focus
ImmunoMedicine is published by Wiley. By OpenAlex counts of its recent articles, its largest topics are Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research, together about 53.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
ImmunoMedicine is a high-quality journal covering all aspects of clinical, translational, and fundamental research in immunology and immunotherapy.
From the journal's Aims & Scope
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immunotherapy and Immune ResponsesImmunology and Microbiology25.8%
- Cancer Immunotherapy and BiomarkersMedicine16.1%
- CAR-T cell therapy researchMedicine11.3%
- T-cell and B-cell ImmunologyImmunology and Microbiology8.1%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology3.2%
- Acute Lymphoblastic Leukemia researchMedicine3.2%
- Cancer Research and TreatmentsBiochemistry, Genetics and Molecular Biology3.2%
- Rheumatoid Arthritis Research and TherapiesMedicine1.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 5OpenAlex ·
- i10-index
- 2OpenAlex ·
- 2-year mean citedness
- 0.5OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 40 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 15 |
| 2025 | 0 | 0 | 22 |
| 2024 | 6 | 6 | 23 |
| 2023 | 4 | 4 | 12 |
| 2022 | 13 | 13 | 9 |
| 2021 | 13 | 13 | 3 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 30 weeksLetPub ·
- Submission to publication (journal-reported)
- about 30 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,410 / GBP 2,180 / USD 2,870 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,870 / EUR 2,410 / GBP 2,180 | — | — | |
| LetPub | USD 2,750 / GBP 2,090 / EUR 2,310 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Not considered
- ImmunoMedicine
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- United States
- Language
- English
- ISSN
- 2510-5345
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about ImmunoMedicine
How long does peer review take at ImmunoMedicine?
Authors report an average review time of about 30 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index ImmunoMedicine?
According to LetPub and DOAJ records, ImmunoMedicine is indexed in DOAJ.
Is ImmunoMedicine open access, and what is the APC?
ImmunoMedicine is a fully open-access journal. APC about USD 2,870.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .